4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical needs. 4SC's pipeline is protected by a comprehensive portfolio of patents and currently comprises one drug candidate in clinical development: resminostat. 4SC aims to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies and/or the eventual marketing and sales of approved drugs in select territories by 4SC itself. 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The Company had 39 employees as of 31 March 2022 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A3E5C40).
| Website | http://www.4sc.de |
| Ticker | VSC |
| Revenue | $17.4 million |
| Employees | View employees |
| Founded | 1997 |
| Address | 22 Fraunhoferstr. Planegg Germany 82152, Planegg, Bavaria 82152, DE |
| Phone | +49 89 7007630 |
| Fax | +49 89 70076329 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Manufacturing General, Biopharma, Manufacturing, Biotechnology, Health Care, Science and Engineering, Therapeutics |
| Competitors | Roche, Novartis, Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Merck Group, Gilead Sciences +52 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular 4Sc Ag employee's phone or email?
4Sc Ag Questions
The 4Sc Ag annual revenue was $17.4 million in 2026.
4Sc Ag is based in Planegg, Bavaria.
The NAICS codes for 4Sc Ag are [3254, 32541, 32, 325].
The SIC codes for 4Sc Ag are [28, 283].
